Breakthrough in Lab-Grown Kidney Development Advances Towards Synthetic Organs

Researchers have developed more mature and complex lab-grown kidney structures, paving the way for synthetic organs and improved kidney disease models. This breakthrough enhances our understanding of kidney development and opens new avenues for transplantation and disease treatment.
A research team led by USC Stem Cell has made significant progress in creating functional synthetic kidneys using lab-grown organoids. Their latest study, published in Cell Stem Cell, details how they developed more mature and complex kidney structures than ever before. These lab-grown assembloids combine key components such as nephrons, the kidney's filtering units, and collecting ducts into integrated structures that mimic natural kidney function.
The team optimized conditions for cultivating both mouse and human assembloids in laboratory settings, then transplanted these structures into live mice. This transplantation allowed the organoids to further mature within the living hosts, growing larger and developing essential features like connective tissue and blood vessels. The process harnessed the natural self-assembly ability of kidney progenitor cells, which proved crucial in achieving maturity.
Remarkably, the mouse assembloids reached a stage comparable to a newborn mouse kidney in gene activity and functionality, marking a significant step beyond previous organoids that only developed to early embryonic stages. Human assembloids also advanced beyond embryonic development, although their exact maturity remains under study due to a lack of newborn human kidney tissue for comparison.
These advancements enable the use of assembloids as high-fidelity models for studying complex kidney diseases, including genetic conditions like autosomal dominant polycystic kidney disease (ADPKD). In experiments, scientists created diseased human assembloids that developed cysts and exhibited features such as inflammation and fibrosis, which are critical in understanding disease progression.
The study underscores the potential of these organoids not only for disease modeling but also as foundational steps toward engineering fully functional synthetic kidneys. This could provide a life-saving solution for the over 100,000 patients in the U.S. awaiting transplants, as well as offer more accurate models for drug testing and disease research.
Lead author Zhongwei Li emphasized that maturing the assembloids within living hosts taps into natural developmental processes, which could be key to constructing complex organs. These findings mark an important milestone in regenerative medicine and hold promise for addressing the global burden of kidney disease.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Four-Drug Regimen Sets New Standard for Treating Multiple Myeloma
A groundbreaking clinical trial introduces a new four-drug combination that significantly improves outcomes for patients with newly diagnosed multiple myeloma, establishing a fresh standard of care.
Gut Microbiome: A Promising Approach for Managing Chronic Fatigue and Long COVID
Emerging research suggests that modulating the gut microbiome with probiotics and microbial therapies offers a promising avenue for managing chronic fatigue and long COVID symptoms by restoring gut health and reducing inflammation.
Effective Strategies to Prevent Dehydration and Heat-Related Illnesses During Summer
Discover effective strategies to stay hydrated and prevent heat-related illnesses during the hot summer months with expert tips and practical advice.



